CA2552177C — Injection device
Assigned to Haselmeier AG · Expires 2007-10-23 · 19y expired
What this patent protects
An injection device comprising a housing (50, 60) with a spring (94) arranged therein in order to accumulate energy for an injection process. The spring (94) impinges upon a squeezing member (92) in a proximal direction to enable injection fluid (16) to be squeezed out of a conta…
USPTO Abstract
An injection device comprising a housing (50, 60) with a spring (94) arranged therein in order to accumulate energy for an injection process. The spring (94) impinges upon a squeezing member (92) in a proximal direction to enable injection fluid (16) to be squeezed out of a container which is displaceably mounted in the housing and which has an injection needle (18) secured to the end thereof. A displacement member (36) is arranged in the housing. Said member can move in a longitudinal direction and push the container in a proximal direction, thereby causing the needle to be inserted. A detent lug (100) is provided on the squeezing member (92). A corresponding detent opening (102) in the displacement member (36) is associated therewith. A control member (70) operating according to the travel path is used to disengage the detent lug (100) from the detent opening (102) when the displacement member (36) has completed a specific travel path in a proximal direction.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.